Bio Green Med Solution Statistics
Total Valuation
BGMS has a market cap or net worth of $13.48 million. The enterprise value is $9.21 million.
Important Dates
The next estimated earnings date is Friday, November 7, 2025.
Earnings Date | Nov 7, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
BGMS has 2.24 million shares outstanding.
Current Share Class | 2.24M |
Shares Outstanding | 2.24M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | +1.39% |
Owned by Insiders (%) | 99.35% |
Owned by Institutions (%) | 1.00% |
Float | 14,648 |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1,347.87 |
Forward PS | n/a |
PB Ratio | 2.63 |
P/TBV Ratio | 3.72 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | 921.37 |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.77, with a Debt / Equity ratio of 0.00.
Current Ratio | 5.77 |
Quick Ratio | 5.63 |
Debt / Equity | 0.00 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -276.80% and return on invested capital (ROIC) is -278.74%.
Return on Equity (ROE) | -276.80% |
Return on Assets (ROA) | -102.83% |
Return on Invested Capital (ROIC) | -278.74% |
Return on Capital Employed (ROCE) | -284.48% |
Revenue Per Employee | $833 |
Profits Per Employee | -$535,667 |
Employee Count | 12 |
Asset Turnover | 0.00 |
Inventory Turnover | n/a |
Taxes
In the past 12 months, BGMS has paid $986,000 in taxes.
Income Tax | 986,000 |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -97.70% in the last 52 weeks. The beta is 0.16, so BGMS's price volatility has been lower than the market average.
Beta (5Y) | 0.16 |
52-Week Price Change | -97.70% |
50-Day Moving Average | 8.53 |
200-Day Moving Average | 49.46 |
Relative Strength Index (RSI) | 35.37 |
Average Volume (20 Days) | 107,743 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BGMS had revenue of $10,000 and -$6.43 million in losses. Loss per share was -$4.06.
Revenue | 10,000 |
Gross Profit | 10,000 |
Operating Income | -10.36M |
Pretax Income | n/a |
Net Income | -6.43M |
EBITDA | -10.36M |
EBIT | -10.36M |
Loss Per Share | -$4.06 |
Full Income Statement Balance Sheet
The company has $4.28 million in cash and $10,000 in debt, giving a net cash position of $4.27 million or $1.90 per share.
Cash & Cash Equivalents | 4.28M |
Total Debt | 10,000 |
Net Cash | 4.27M |
Net Cash Per Share | $1.90 |
Equity (Book Value) | 3.63M |
Book Value Per Share | 2.29 |
Working Capital | 3.62M |
Full Balance Sheet Cash Flow
Operating Cash Flow | -8.73M |
Capital Expenditures | n/a |
Free Cash Flow | -8.73M |
FCF Per Share | -$3.90 |
Full Cash Flow Statement Margins
Gross Margin | 100.00% |
Operating Margin | -103,580.00% |
Pretax Margin | -54,220.00% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
BGMS does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | -47.69% |
FCF Yield | -64.74% |
Analyst Forecast
Price Target | n/a |
Price Target Difference | n/a |
Analyst Consensus | n/a |
Analyst Count | n/a |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
The last stock split was on July 7, 2025. It was a reverse split with a ratio of 1:15.
Last Split Date | Jul 7, 2025 |
Split Type | Reverse |
Split Ratio | 1:15 |
Scores
BGMS has an Altman Z-Score of -132.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -132.54 |
Piotroski F-Score | 1 |